BAP18 facilitates CTCF-mediated chromatin accessible to regulate enhancer activity in breast cancer
Ge Sun,Yuntao Wei,Baosheng Zhou,Manlin Wang,Ruina Luan,Yu Bai,Hao Li,Shan Wang,Dantong Zheng,Chunyu Wang,Shengli Wang,Kai Zeng,Shuchang Liu,Lin Lin,Mingcong He,Qiang Zhang,Yue Zhao
DOI: https://doi.org/10.1038/s41418-023-01135-y
IF: 12.067
2023-02-25
Cell Death and Differentiation
Abstract:The estrogen receptor alpha (ERα) signaling pathway is a crucial target for ERα-positive breast cancer therapeutic strategies. Co-regulators and other transcription factors cooperate for effective ERα-related enhancer activation. Recent studies demonstrate that the transcription factor CTCF is essential to participate in ERα/E2-induced enhancer transactivation. However, the mechanism of how CTCF is achieved remains unknown. Here, we provided evidence that BAP18 is required for CTCF recruitment on ERα-enriched enhancers, facilitating CTCF-mediated chromatin accessibility to promote enhancer RNAs transcription. Consistently, GRO-seq demonstrates that the enhancer activity is positively correlated with BAP18 enrichment. Furthermore, BAP18 interacts with SMARCA1/BPTF to accelerate the recruitment of CTCF to ERα-related enhancers. Interestingly, BAP18 is involved in chromatin accessibility within enhancer regions, thereby increasing enhancer transactivation and enhancer-promoter looping. BAP18 depletion increases the sensitivity of anti-estrogen and anti-enhancer treatment in MCF7 cells. Collectively, our study indicates that BAP18 coordinates with CTCF to enlarge the transactivation of ERα-related enhancers, providing a better understanding of BAP18/CTCF coupling chromatin remodeling and E-P looping in the regulation of enhancer transcription.
cell biology,biochemistry & molecular biology